Four non‐HLA regions reached genome‐wide significance, SDK2 and LINC00924 (both novel) and STAT4 in the whole IIM cohort, with evidence of independent variants in STAT4, and NAB1 in the polymyositis (PM) subgroup. Here, STAT4 is linked to polymyositis.